The 20 Best Non-Small Cell Lung Cancer (NSCLC) Doctors Near Me in Merritt Island, FL

Mark Socinski is an Oncologist practicing medicine in Orlando, Florida. Dr. Socinski is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Socinski is currently accepting new patients.

Jhanelle Gray is an Oncologist practicing medicine in Tampa, Florida. Dr. Gray is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Tissue Biopsy. Dr. Gray is currently accepting new patients.

Alberto Chiappori is an Oncologist practicing medicine in Tampa, Florida. Dr. Chiappori is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Chiappori is currently accepting new patients.

Eric Haura is an Oncologist practicing medicine in Tampa, Florida. Dr. Haura is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer.

Luis Raez is a Hematologist and an Oncologist practicing medicine in Pembroke Pines, Florida. Dr. Raez is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Lung Adenocarcinoma, and Tissue Biopsy. Dr. Raez is currently accepting new patients.

Tawee Tanvetyanon is an Oncologist practicing medicine in Tampa, Florida. Dr. Tanvetyanon is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Mesothelioma, Small Cell Lung Cancer (SCLC), and Thymectomy. Dr. Tanvetyanon is currently accepting new patients.

Tarek Mekhail is an Oncologist practicing medicine in Orlando, Florida. Dr. Mekhail is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 131 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Tissue Biopsy. Dr. Mekhail is currently accepting new patients.

Yanyan Lou is an Oncologist practicing medicine in Jacksonville, Florida. Dr. Lou is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Lung Adenocarcinoma, Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), and Tissue Biopsy.

Andreas Saltos is a Hematologist and an Oncologist practicing medicine in Tampa, Florida. Dr. Saltos is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Saltos is currently accepting new patients.

Evan Alley is a Hematologist Oncology provider practicing medicine in Stuart, Florida. Dr. Alley is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Metastatic Pleural Tumor. Dr. Alley is board certified in American Board Of Internal Medicine, 2002.

Hiren Mehta is an Intensive Care Medicine provider practicing medicine in Gainesville, Florida. Dr. Mehta is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Lung Nodules, Lung Cancer, Small Cell Lung Cancer (SCLC), Endoscopy, and Gastrostomy.

Diana Saravia is a Hematologist Oncology provider practicing medicine in Weston, Florida. She has been practicing medicine for over 18 years. Dr. Saravia is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Breast Cancer, and HER-2 Positive Breast Cancer. Dr. Saravia is board certified in American Board Of Internal Medicine, 2017.

Jose Lutzky, M.D., is a triple board-certified hematologist and oncologist at Sylvester Comprehensive Cancer Center. At Sylvester, Dr. Lutzky works as part of a multidisciplinary team of cancer experts and researchers. He earned his medical degree from Universidade Federal do Rio Grande do Sul. Dr. Lutzky is fluent in Spanish and Portuguese and his career highlights include: Recognized for his expertise in melanoma, basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma. Triple board certified in hematology, oncology and internal medicine Completed his residency in internal medicine at Mount Sinai Medical Center in Miami Beach, Florida Fellowship in hematology/oncology at Columbia Universitys New York-Presbyterian Hospital Extensive clinical research experience and interests Authored numerous articles and abstracts Fellow of the American College of Physicians. Dr. Lutzky is rated as an Advanced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Melanoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Uveal Melanoma. Dr. Lutzky is currently accepting new patients.

Manish Patel is a Hematologist and an Oncologist practicing medicine in Sarasota, Florida. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Hodgkin Lymphoma, Non-Small Cell Lung Cancer (NSCLC), Prostatectomy, and Nephrectomy. Dr. Patel is board certified in American Board Of Internal Medicine. Dr. Patel is currently accepting new patients.

Lav Goyal is a Radiation Oncologist practicing medicine in Ft Lauderdale, Florida. Dr. Goyal is rated as an Advanced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Lung Cancer. Dr. Goyal is currently accepting new patients.

Estelamari Rodriguez is an Oncologist practicing medicine in Miami, Florida. Dr. Rodriguez is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Rodriguez is currently accepting new patients.

Dr. Gilberto Lopes is a medical oncologist and researcher who focuses on new anticancer drug development and global oncology. He has published more than 270 scientific papers and has led hundreds of clinical trials. Dr. Lopes was the main investigator of Keynote 42, a clinical trial that demonstrated the efficacy of the immunotherapy drug pembrolizumab in people living with lung cancer. This groundbreaking study led to one of the FDA approvals of pembrolizumab. Additionally, Dr. Lopes has contributed significantly to the development of several chemotherapies and targeted medications that address specific molecular changes in tumors. He also does research in cancer control, policy and health economics and is active in improving access to cancer medications in underserved settings. Dr. Lopes is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Lopes is currently accepting new patients.

Jennifer Tseng, MD, hematologist/medical oncologist, is the Thoracic/Head and Neck Specialty Section leader for Medical Oncology and the associate director of Clinical Research for Medical Oncology at Orlando Health Cancer Institute.Dr. Tseng received her medical degree from Duke University School of Medicine. She completed her residency and served as assistant chief resident in internal medicine at Duke University Medical Center. She completed a fellowship in medical oncology and hematology at The University of Texas MD Anderson Cancer Center in Houston. She is board-certified in internal medicine and medical oncology and board-eligible in hematology. Dr. Tseng has received several honors and awards, including the C.D. Howe Award for clinical excellence in medical oncology and a Clinical Research Award from MD Anderson, the American Medical Women's Award, Hewlett Packard Award, the Alpha Omega Alpha Research Symposium Award from Duke University and a Beneficial-Hodgson scholarship from The Johns Hopkins University. She was also awarded Attending of the Year from the Internal Medicine Residency Program from Orlando Regional Medical Center and received the Exemplary Physician Colleague Award from Orlando Health in 2009.In addition to her clinical studies, Dr. Tseng has published research on various topics including molecular alterations in lung cancer and novel agents in the treatment of head and neck cancer. She has recently presented at the Annual Thoracic Oncology Symposium of the Puerto Rican Society of Hematology Oncology and spoke on neoadjuvant and adjuvant treatment strategies in lung cancer. Dr. Tseng is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Lung Adenocarcinoma. Dr. Tseng is board certified in American Board Of Internal Med. - Medical Oncology and American Board Of Internal Medicine.

Luis Herrera, MD, thoracic surgeon, is the medical director of the Rod Taylor Thoracic Care Center at Orlando Health Cancer Institute. He is a member of the Thoracic/Head and Neck Cancers Specialty Section. He joined Orlando Health Cancer Institute from The University of Texas MD Anderson Cancer Center in Houston where he served as chief resident of thoracic surgery and is currently appointed as an adjunct assistant professor of surgery in the Department of Thoracic Surgery.Board-certified in general surgery and thoracic surgery, Dr. Herrera specializes in surgery for tumors of the chest, including cancer of the lung, esophagus, chest wall and mediastinum and also treats benign disorders of the esophagus. Dr. Herrera has expertise in minimally invasive thoracic surgery, advanced pulmonary resections, and esophagectomy. He also specializes in VATS (video assisted thoracic surgery), laparoscopic and robotic surgery. In addition, Dr. Herrera serves as an expert reviewer of other doctors performing robotic surgery through the C-SATS performance review and training program.Fluent in English and Spanish, Dr. Herrera graduated summa cum laude with his medical degree and magna cum laude with a bachelor's in biology from the University of Puerto Rico. He fulfilled a general surgery residency at the University of Pittsburgh and a cardiothoracic surgery residency at MD Anderson Cancer Center and the Texas Heart Institute in Houston, focusing on thoracic surgical oncology.Dr. Herrera is involved in basic and translational research focusing on new treatments for lung and esophageal cancer. He has received several awards for his work, including the Minority Scholar Award in Cancer Research from the American Association for Cancer Research, the National Institutes of Health Minority Supplement Grant from the National Cancer Institute and the United States Surgical Corporation Resident Research Grant.He has been published in the Journal of Thoracic and Cardiovascular Surgery, The Annals of Thoracic Surgery, Neoplasia, Clinical Chemistry, Nanomedicine and has given presentations at several national meetings. Dr. Herrera is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, Thymectomy, and Endoscopy. Dr. Herrera is board certified in American Board Of Surgery and American Board Of Thoracic Surgery.

Raja Mudad is an Otolaryngologist and an Oncologist practicing medicine in Doral, Florida. Dr. Mudad is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Lung Adenocarcinoma. Dr. Mudad is currently accepting new patients.